{"ticker": {"uuid": "a8a1958e-2ccb-4df7-bc10-bc89c0a4f6e7", "symbol": "AZN", "name": "AstraZeneca PLC", "exchange": "LSE", "country": "GB", "sector": "Healthcare", "industry": "Drug Manufacturers - General"}, "articles": [{"title": "Why AstraZeneca (LSE:AZN) Is Reframing Blue-Chip Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxPS0ZCVUU4djNiTFFGT25LR0JnN29DT2VJM2JmUjRneHB6S0MzSS11Z0xnM3U0b3AwUFJoSTlRQlhQZGlSQk1jT3IxT2VTbk82R2VFR3d1MDJUTzZsdWZEcnVuWlpxM3BVZnRQVTQwTm5XZFJlZ2ZGbzdGb1h6YzJEUjdEdTZTNWZBUFZnQ0U5Z2NzcldBci12RndSbWQ?oc=5", "source_name": "Kalkine Media", "published_at": "2026-06-22T05:48:00+00:00", "published_display": "22 Jun 2026 05:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why AstraZeneca (LSE:AZN) Is Back In London\u2019s Blue-Chip Debate", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNODBsU1hCb1k0MWlzUl9VeXo3RkowQmJVOThGaUhTelc0TXU1N21taXdCUGZfczNtcmZVekxjVmM3RUVJQWhTdjFUNFFfZDRZeV81NWpzanZtdlJZdU4zXzF6aFpzLWpFSXhFNE9zQXBQaG90eTJzZlhZSHVJUHRJdVRybXVsOFU4Ujh4ZGJuZkMyTzVpNzVVaTFvNWJJSXNzQWU4cGVGcw?oc=5", "source_name": "Kalkine Media", "published_at": "2026-06-22T05:48:00+00:00", "published_display": "22 Jun 2026 05:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca (LSE:AZN) Stock Fair Value Edges Lower After Pipeline And Pricing Debate", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxNalVkSVBsa1oyTE1DU25VZjlQNWNrWkFTOFRFMEItWjFzaThNMk92WkRydTVCbnBhOFdCUGN0LU1TYUFyd0RfQml6eWdzM1YtV3BGdGZnQ1h6cHlMd1R2U2FtREI4dXhyTktUWW0xNmVXM1lWTzhlN2tleTN2UWktMmNXclE2SWFoT3NZVnh0emctblFYU2c?oc=5", "source_name": "Market source", "published_at": "2026-06-20T02:07:00+00:00", "published_display": "20 Jun 2026 02:07", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca (LSE:AZN) Stock Could Be 20.2% Below Fair Value After Recent Pullback", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-19T16:33:51+00:00", "published_display": "19 Jun 2026 16:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca (LSE:AZN) Stock Could Be 20.2% Undervalued After Recent Pullback", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOYzJ1VmltcFhibVVwU0stc19wdXd3Z0tKdU1wTUFrcjEzeTI2RnhHc3gxX3YybVZJSVBhQmVreldvLU9SeHVmLTNTTjU0WlpZSDA0aWtzWFhzWW1RS01VYzJTUE5DUDM4RGFtZWFrcWQ1NnFWakZuZUw0VTA4WWFxRWg1X3l0Y2hDZEQ1ZzZNNkFFT1R2ZlYyLVFwUHk?oc=5", "source_name": "Market source", "published_at": "2026-06-19T13:09:58+00:00", "published_display": "19 Jun 2026 13:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AZN News | ASTRAZENECA PLC (NYSE:AZN)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTFBzTy1SNW8tSjBhVk55dU9wRjNZN051UXhHOWRrSnBPcE8wajNYQ1JQV2FFRE1WbnRsZVF0UnNBcjRCYmgxM1l4QU4wS2U5X0ZjeG5ER2dwZW0yZw?oc=5", "source_name": "ChartMill", "published_at": "2026-06-19T00:04:00+00:00", "published_display": "19 Jun 2026 00:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astrazeneca (AZN) Stock Drops Despite Market Gains: Important Facts to Note", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxQdFRlQ1h2eDM0VHYwa253dVlmYmdfeFBnX2s2VkVtS3RLZU5NZVBsbWs5NDVLaVRFakFhTW91QUVTTU4zM2VYSjc0Q0Exc191TGZoM0xsVnlYaGZUTzZIR0hmZmFlUU1VdFdZejR5TXdoRklwVFlLZnlSeG9Xa1ZiT1pYekZKX2pnX011MzAzS0R2ekpVaW83empGb045NUFLU0E?oc=5", "source_name": "Market source", "published_at": "2026-06-18T22:15:04+00:00", "published_display": "18 Jun 2026 22:15", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca (AZN) officer receives Ordinary Share award under incentive plan", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxOcHZERjlmdHNzTWs4azdJV2ttdkMwc240OGF1NGExRW5mUldJT3VkaFgyOFJjVmEyeTB1TjAwV0lUeHdPc045alVtSnBkbk1KcFZNTmpyMEszbnB2NFFwNnpyeGxTTnlVbkc5M21xTlZldjVLMl9lV09WbEtNYUlmR193RHpXWXNTQmpVYzV5TUp4clJEeF9RNUFFTzV0enJCLTRWbDdhYVp3WDdF?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-16T20:05:06+00:00", "published_display": "16 Jun 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FDA Accepts AstraZeneca's Filing for Expanded Use of Ultomiris", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQeHdzVmdTTU04S19jTEcycjZTaU1qN1Q4eEFlQzZ6cWVTelZpSTJQckhJOWdIaHk1TkRSdUlYZm9SZjdMVTZyM1RYS3IxVDBMbU44MUVoVWlmQ2JVcmZaYnpaZy1vdEtYU3Bickk3T2FsaGVzWUp0ekdUZjhzbzdqbWp3N3FqRmRHeXowSGJVTF9STDdaaFNTa2ZwRW9xSnpKNzk1bVNGcTB6bzNFT1RLZGNmNGpWTVRxdEE?oc=5", "source_name": "TradingView", "published_at": "2026-06-16T16:53:00+00:00", "published_display": "16 Jun 2026 16:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca Stock Down 7% in 3 Months: Should You Buy, Sell or Hold?", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxPem5qdkVUNnp0bTNzcVdSeW5IMXlkNXNzck1USGJlcmppdURocFotRHJ1aVNYS2J6VVpqeDVZS29RYWNVRXMtc1FUeDBlRTA4QThTX1U2TGMxU1NuQnptS2txaU1aUEg4VlE3amJoZ2JZUFB5Y25vU2VELTdBaWFBaV9wbDNzN25QMUhwMW4yNDEwbjA5NTZtLTg0T2J6dVN6cFFqQWh6X1AwUWdZVkpjZE90SmRtOGFwaFBNZg?oc=5", "source_name": "TradingView", "published_at": "2026-06-16T14:07:00+00:00", "published_display": "16 Jun 2026 14:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca Stock And Two Cash Flow Sleepers The Market Misprices", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-16T13:16:30+00:00", "published_display": "16 Jun 2026 13:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca PLC (AZN) Stock Analysis: Robust Revenue Growth and a 20.73% Upside Potential", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxQdlJobmhTZzJxYnJtN2NQc0dWdElmUzZyVTRSU1R2QzNsMEs0UTR0MXl3a01YZ08xZVUtU1FfNXNZRkktbGRYclhVOTdvWnZQR1J3UVhKUnhhQWw1TlMxM0JHLW9nbG9mYXozY3UtMURPdjRiWWZNNXY2ZVJBbW9tXzQzLVZyQ2FoQ2I5cUhTUjNnbVFfbnBqbk1IX2N4QXVfV09nb1FoMUlQd0s1cEpDN1JlSGhjNmRfZmdnUTYwUXBERkZScnhQMDExSWNQb2pFeEE?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-06-09T08:39:56+00:00", "published_display": "09 Jun 2026 08:39", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Too Late To Reassess AstraZeneca (LSE:AZN) After Its Strong Multi\u2011Year Run?", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxOa3VRV043YkI2dmVxQ1g2MDkyazR4b29RcmU3bHYzVDcwV2Y2SXBIVFhoZ1RERjJDUXFyQjJsTlAwemI5TFVDbHpWVXdMdGpYLWdjQndoV09aRExjang0TW9jaE53dmRCQzMwM29Ib2JGTTRhU3pjd2U2M0VsOWZZQnQwT3hNRlpVTXV0Z2pKWHBXUXhxMXNHSnRPWFBIUQ?oc=5", "source_name": "Market source", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Too Late To Consider AstraZeneca (LSE:AZN) After Its 30.8% One-Year Surge?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca chief warns group could withhold new drugs in Europe", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxOU2U1Wkd1RzVIYUFtNFRhTG5SbDNlR284cENmaWdkcVQ5TC15UmVWWkNYOWFuT1BoclBQWEowd3lONXNoRE9SOEJJTGd2alNoUUFoSElmVVo3MlhLLVFaVDBnMElfY1dDdlEyLWpsSUxuVk1lUXlKbGFWVGhieWNZV0o1dDM?oc=5", "source_name": "Financial Times", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca (LSE:AZN) Valuation Check After Recent Share Price Weakness And Pipeline Growth Expectations", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca (AZN) admits 14,120 new employee scheme shares to LSE", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxOUlhDNWNkdzJuS3NsOWwzb2ZncDVvbk84cWEycE9TQnU2cktMVlo2bnE5UTBKTkNzSEFlTHhBaWZGMU90aFRZaW1UUVpVUnkyZ0QtaGo5YmVzalBLVzhVUk04cmR3MkxSYmlLQkptNmpXUzRZT0stSHZPSldtOWVuN2dJT2NocUNMcEZsQ2VmV1JDNS1BZUI3bF9Da0ltTDVDLTI0Y21NenFXZ2xDLTgw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca PLC Stock (AZN) Closed Down by 3.17% on Jun 1: Facts Behind the Movement", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxPVFg1VE5ObzZBRjF6RGoyVlBRTEozbE91OUI1NXlEWHg0eWR1X19rWjFqSUlnVERWTGVTOFR6YklPclJ5NEpzRVphQUZpdUpHS2libVRDYzEwN3FUZlFrd2JqeWgzMC1ac2hHNXJ5YXM2b1ZOZXJuMUhfakJGdXhYSTd2RWhTZjZjYnc?oc=5", "source_name": "TradingKey", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Fresh Look At AstraZeneca (LSE:AZN) Valuation After Recent Share Price Weakness", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNeHZ6UHg5WDVmaV9qaFNPaDNYeFlycnpOUGZwX1F3OFJtUnBGZkNfQ2RWY2Z6Ty1PeXNiUlNDSGZ3cEFwMGlKaHhySTUtdEI2cVhKVEc2YS1jV0NGMGQwZnBVLTg0cUNfa2hPS2pseDBoVERvcVQ0a1R3V2lFWjV0dU5FTFp1VzljYi11aWxYY25vNlRyb3RPbjBBQQ?oc=5", "source_name": "Market source", "published_at": "2026-05-16T07:00:00+00:00", "published_display": "16 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is AstraZeneca PLC (AZN) A Good Stock To Buy Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNX1hhOU1xaVRCYVNQNHlvd1Q1VmhpdjFybG9nUlIzai1ObmVuY3FVbmVWYUFOTkxQeW5yaTlXdkpPandQRXhHUXRNZnc0U2ZXYjN2NjFNbHA4QnhuSUZNYjJDOTFkTkp1TGs5bmNTakk5d2xWbFZWSHhuRjR5aUluTy1ST3BYNDlmeTVUd0pvRFRHSjlOUDlkRGprWQ?oc=5", "source_name": "Market source", "published_at": "2026-05-03T07:00:00+00:00", "published_display": "03 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UK's FTSE 100 Closes Lower; NatWest, AstraZeneca Shares Down", "summary": "", "url": "https://news.google.com/rss/articles/CBMifEFVX3lxTE9HVTJReEE0TnBtblpTS0xvOTRrMzB0YzZvMGRVb0NvN1dWaFhwVTB5WTlxLTFXS09lQ2hnVDZld0M4cmstRzBBdzdSME44akpxb1ZBN1d4UkJRSkk1eFNUd21GZGRwOGpZZ3prNjZOanJpTmh0QXlDXzlFMmI?oc=5", "source_name": "Market source", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UK's FTSE 100 slips as losses in energy stocks and AstraZeneca weigh", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxOU3FCZWNaMmxZQ0RzNVdQblRrMldOQkJlMEFGdVZSZVRENUEzTWdHSHJCN28xTGZFMl9tWC1NZkQtdkotbGl4Y2RQelAtekNXM2JKRzZrMklQM0hKSld3QUR5Qk51MDA5MzI4SE5JVktWM1dZRVdsTFd4dUpPTHBOcGZIeEVTdjVvbjd0ME92N2h5RlFnZGVpa3p6M09kcWlnSkxocA?oc=5", "source_name": "Reuters", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astrazeneca (AZN) Stock Falls Amid Market Uptick: What Investors Need to Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNN2Nnc0hZMHM1V0o0QlpiTUZUTElrRDMxWFZ3SUttSk41Z01OWHFRV1dyY0ZTZGVrcEplSUJaNzdsWmQ0OTliY0MwZGxSNzg0MmVOZ3k4OU1OZXJJMEdhcWhZcmhRYl9TS2wwY3hZSkpIVERJdkJEWnhYZ2NTVU56V0x0UTV1Nm95YzE5NF84UGRtek1XNHF0VjE2dUJpUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-15T07:00:00+00:00", "published_display": "15 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca admits 45,750 new shares to London Stock Exchange main market", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQaUZCRUJhTjhudnRrc3k0eG82Y1BhS3h1NjFyTGVyTzRFR0ZEWjhMT3JYRm9ka1hLYnhhT0lNemJtY3pvQVpzcFowTU51REh0MGd2TGxQSlAyQ3RSMkkwLVlDd2U2a0NrWDVlWnhxUzhPY3pmaXRHQmxyclR1LWlrUzdfSXJhZzFJdkoxWFN5ZkxKUDRRQXVuaHN4dExfZUlPNXIwejVrMnFZR3NzclNTRG5vTC1MMlpwRDBQZlA5blRxZ1dKSUFz?oc=5", "source_name": "Investing.com", "published_at": "2026-03-20T07:00:00+00:00", "published_display": "20 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca CEO hails NHS drug price deal but keeps pause on \u00a3200m UK investment", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxQU2hHTTd4c2RfUHh5MnhBSW5MZm1kaVVZRFBydTBqY0RnV1hGdGI3S1c4MDVhRDZSNmVmRXFnOTVPa3B6U2NzaEl0d1NiSGxoeEhfTEVaLVNjTjh1YnhobFlsLXdnRkFiUm5pblNaUmRhSmw3SHh6TmNNbF9ndVB1YjRPWkNGN3JCdHRMeF9Ob081Sk5zdmQzTGVYaXo5NFNURm5LamRXZWkxUmQwTW1jeHAxXzVxUFB1UGViNElhVQ?oc=5", "source_name": "The Guardian", "published_at": "2026-02-10T08:00:00+00:00", "published_display": "10 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FTSE 100 today: Index falls as BP halts buyback; AstraZeneca, Barclays in focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxNbU1zX3Nva3dsQ0k5SmNNTXQxTmc0STlHR1MzT3FZWVdpV1M0WVZIZk83LXltMWJwV09QV1BHWE13LUFWcmk5bVo1X0FVWmZQclBJM2lvTmtJOVl4N1BsdTE2Ujl6ZWFxN1dSaVplSGZMTElraW15OU1SQUQ2Ny01MDJ5eGdDNkNoWXlIQTdldjVYQ0hOZUxLUlN5TTl4NGFBMWlwU09zWWNnSk1STWFwYmREMHZVOF9oWmJFdmFNTl9rVmdYM1BqOUl3b2E?oc=5", "source_name": "Investing.com UK", "published_at": "2026-02-10T08:00:00+00:00", "published_display": "10 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca bets big on China", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxNM3lhNkJoU2tCS3U2UXRqczhIS0ZoREVidnNQR0NXUDN3bXJZeDJrM0cxRl94TE1CUy1WWXRRbEVxM3VRV1d3Q1VXNV9DS0R2OHBPdHZuOERkV3B6c2UwYWpmRGZIRkY4c0dyR3Jjc3lkUTNUYVZEamxQUVp6THo5cDFB?oc=5", "source_name": "fDi Intelligence", "published_at": "2026-02-09T08:00:00+00:00", "published_display": "09 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca begins trading on the New York Stock Exchange", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPMWtuQzczY3ltajY4cUdBOVJGcEdDcXN1Nk12RVhwWU9MYXFvYzc1ckpZeHB3bnFlQ1A2OG01S3lTUDJqQUdEYUVXS2FpTXBudVdYTC1aX2I0MGRUdVNSMzBJRGZtTnM3YTNXcXp0eEVWaEpJb1E0TTlWY2J5VjNSdWtjQTFIMV8ySENONTJ5MzI2ZHVvLWFjaUtpejRacWxELXc?oc=5", "source_name": "AstraZeneca", "published_at": "2026-02-02T08:00:00+00:00", "published_display": "02 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca begins trading on New York Stock Exchange", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxPYlI0TUlrcEVEMXBEcjlKT2tWNi10X1IxUFctMmxGY0JibnFQZG5vM2tya2lEY0Q1YVQ2bHdqT0tzckpmNnlIRzUzd3hpUzBKenBUX2ZRckRia1NOTk13amx1Q25ZeGsxS3VjVk1wT0Z0NXVJVW91ejUxYXZvWmFPYkFCWk4wc1BRMXdmeVBRRVVPRTdB0gGaAUFVX3lxTE1qdEhsdGFONWxpZ2k4NlJNcEhWUU04UmtmVUVvNmtybk12UHkwMnR5eHNtcmdlYkM4a21tVFk2MjUwWU9aakNnTXlWMzFnUGVYdEw0Q0dNZkdHamx2ZzA1NzVwSEQxNTFUcTdsSU9jc2NTckkxMlJnSHRZYjY3VVItX0ZHaF83WmJyM2t5OTZMNURyYnFydWlFbmc?oc=5", "source_name": "Business Live", "published_at": "2026-02-02T08:00:00+00:00", "published_display": "02 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca to complete direct listing of ordinary shares and all US debt securities on the New York Stock Exchange", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQY3QzY1NFN2NGUEJWNkdXcDlObHh4azVkY0YzRzBtZzItYWpiSmxqc1Y5RmxLYkVzbi1oWVhubHY5azRzYkpTVFRWY2I5SzluelBCMUtXdkJQVURUWDU0bFBTLWxwUkVlWG1obk5YSFBXTlF6YkNiRFhCRkNhcHhBeE55N1R0TWxhNUVmdkZ5WXR5dWU3YmpTUE93SFQ4RDV3TjQ3OGxfdDNHNXNrVWlCOWxn?oc=5", "source_name": "AstraZeneca", "published_at": "2026-01-20T08:00:00+00:00", "published_display": "20 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca Stock Becomes UK\u2019s Biggest Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMifkFVX3lxTE5nYVRlM2RkSVpIYklFdE1CcGZQbXRES3djZVA5NTFHZUpBVVRDSWoxaUF2X1VZZkpSRmtiUlhOQnY1UDl2UlN0WUxGY3hFbTU2VF83b2xEUklVYU1GS29iRDRDWFRPMjMtMXoxMnlENUFyOTFEV1ZOUzBIcmN0QQ?oc=5", "source_name": "Pharmaceutical Executive", "published_at": "2025-11-11T08:00:00+00:00", "published_display": "11 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FTSE 100 closes at record high on rate cut bets; AstraZeneca shines", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxOQkpMUVhlQ2d3QzZ3THRrdEhRWG0wSFR4Z094NDlqN1JJdmNVV0xBYzZtSUlZM3c2bExMVXVoOE1rSUl0SzczS1RXaVlIOXRoSDJSSVpYWjFTb2hvbzMxaWZkTTZid2t4eVNZcFh3SUJRb1JaYnk3VWRUaC1vNEx4MVR4aTR6ei00eTNrOWxJMEF0Nmo0N1B4d29mQUVHaGlVUmt4RmExLUFKZ1BpRFRYQnJhbUZUMlQ2aUR2S01jODNqc1F5WTJpOU1QYURYUQ?oc=5", "source_name": "Reuters", "published_at": "2025-11-11T08:00:00+00:00", "published_display": "11 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca to upgrade US listing in \u2018knock-back for London\u2019", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPdnlmNE5tNzNsZGU3NmdaU0dNSDZkZTlDdmp3WkRmWHA3cXZkQ28xMWl2Q0RmZkliN0pDOWNDbDhfZ3g0VElVRVJrc0hBVEFwZ2d5YzlGMUFnN1hSRURiTmVVdXhxRXNSTmljbDdyZEVDNXFXeVFfZUdPQlEyb0RfcjVLb3VURWdfRDEzeXdIWjIxTno5Qkc5cVZ2cTRxQmVlNkUyVEpYaTNTX3ltM3BUZHQwQmVNckNUcG5QUS1Ic2E?oc=5", "source_name": "The Guardian", "published_at": "2025-09-29T07:00:00+00:00", "published_display": "29 Sep 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "'Knock-back for London' as AstraZeneca sells shares directly on rival New York Stock Exchange", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQSzh0UHpoVjlBcUJNMVNPVjBRUEFSLXpfemZIM3VKc212QzFweTJxVkt0V0VPbldnaklzRUdEdzRmX3Q2Q29FRlgwUERqNGZ5bFIwZzlwOERFNUg4bXFIMVg3VEdpZFZHR0F6MVlnTlV0SnlhYVNxVm5GUmhaLXpsbnFuR0tyZ3BVekNULVV4ZXktczVGb254RDBZazRlM0RrZ2RNeGt1QnRVR0prNnNEUXdOVVVSME9ZOWJaQ2RYS2dPbTBSeGc?oc=5", "source_name": "Sky News", "published_at": "2025-09-29T07:00:00+00:00", "published_display": "29 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca to harmonise its listing structure across the London Stock Exchange, Nasdaq Stockholm and New York Stock Exchange", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgJBVV95cUxOUm01dC1PRGdrMVR1YlhsX2ZHa0FNUTdRU2QzenJuOVdJVlBadHJCVmRfTEJEZFNuNWlSZFZrYzNFSVlCU2I4MkxHUWZ0bU5TS1BXNFhKbE1OUl9STllKTGRjd2VzZ2RUdjNxS3RtUmlZR3dsV3FEVEJqSU92RGQzMVJJSlZXckxoNzNMLWxwNWRxUVRTaE5wTTBrWHJPTDc0SWNQNjhaeGplelZGc3dudkY5WVJjejE3aUV2MnExZHBSQnBGXzZKWTVrSU5DYlByanUxVm1BVXl5VHZDa3dCVlYyUUVKQWdQNHVMd3JmWGh3X05Nc041aDFXU2pEVXBRNndOZ29IR29hX18yZ0xpUGdiWl9CNHJxWmc?oc=5", "source_name": "AstraZeneca", "published_at": "2025-09-29T07:00:00+00:00", "published_display": "29 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca to overhaul US listing but remain on London market and keep UK HQ", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxObGlaNVhDd1VTbnRXdnE0OEpVTjR2dlZIX0RZOUpjaV9FOWZIZ3Vic1IwRGVNT1puSmVtSUxMOVp3a2tBdFBiTzBuSlNiRGdqak8xTmRLMGVUalFwU2ktWVR2VHhHMXk0VzFuYzBYUG1BdW1GSm4zdnRDS2VEOTRaZU0zLXNjMmVZTHlTZ3VDVlo?oc=5", "source_name": "Market source", "published_at": "2025-09-29T07:00:00+00:00", "published_display": "29 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Why AstraZeneca (LSE:AZN) Is Reframing Blue-Chip Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxPS0ZCVUU4djNiTFFGT25LR0JnN29DT2VJM2JmUjRneHB6S0MzSS11Z0xnM3U0b3AwUFJoSTlRQlhQZGlSQk1jT3IxT2VTbk82R2VFR3d1MDJUTzZsdWZEcnVuWlpxM3BVZnRQVTQwTm5XZFJlZ2ZGbzdGb1h6YzJEUjdEdTZTNWZBUFZnQ0U5Z2NzcldBci12RndSbWQ?oc=5", "source_name": "Kalkine Media", "published_at": "2026-06-22T05:48:00+00:00", "published_display": "22 Jun 2026 05:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why AstraZeneca (LSE:AZN) Is Back In London\u2019s Blue-Chip Debate", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNODBsU1hCb1k0MWlzUl9VeXo3RkowQmJVOThGaUhTelc0TXU1N21taXdCUGZfczNtcmZVekxjVmM3RUVJQWhTdjFUNFFfZDRZeV81NWpzanZtdlJZdU4zXzF6aFpzLWpFSXhFNE9zQXBQaG90eTJzZlhZSHVJUHRJdVRybXVsOFU4Ujh4ZGJuZkMyTzVpNzVVaTFvNWJJSXNzQWU4cGVGcw?oc=5", "source_name": "Kalkine Media", "published_at": "2026-06-22T05:48:00+00:00", "published_display": "22 Jun 2026 05:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca (LSE:AZN) Stock Fair Value Edges Lower After Pipeline And Pricing Debate", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxNalVkSVBsa1oyTE1DU25VZjlQNWNrWkFTOFRFMEItWjFzaThNMk92WkRydTVCbnBhOFdCUGN0LU1TYUFyd0RfQml6eWdzM1YtV3BGdGZnQ1h6cHlMd1R2U2FtREI4dXhyTktUWW0xNmVXM1lWTzhlN2tleTN2UWktMmNXclE2SWFoT3NZVnh0emctblFYU2c?oc=5", "source_name": "Market source", "published_at": "2026-06-20T02:07:00+00:00", "published_display": "20 Jun 2026 02:07", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca (LSE:AZN) Stock Could Be 20.2% Below Fair Value After Recent Pullback", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-19T16:33:51+00:00", "published_display": "19 Jun 2026 16:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca (LSE:AZN) Stock Could Be 20.2% Undervalued After Recent Pullback", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOYzJ1VmltcFhibVVwU0stc19wdXd3Z0tKdU1wTUFrcjEzeTI2RnhHc3gxX3YybVZJSVBhQmVreldvLU9SeHVmLTNTTjU0WlpZSDA0aWtzWFhzWW1RS01VYzJTUE5DUDM4RGFtZWFrcWQ1NnFWakZuZUw0VTA4WWFxRWg1X3l0Y2hDZEQ1ZzZNNkFFT1R2ZlYyLVFwUHk?oc=5", "source_name": "Market source", "published_at": "2026-06-19T13:09:58+00:00", "published_display": "19 Jun 2026 13:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AZN News | ASTRAZENECA PLC (NYSE:AZN)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTFBzTy1SNW8tSjBhVk55dU9wRjNZN051UXhHOWRrSnBPcE8wajNYQ1JQV2FFRE1WbnRsZVF0UnNBcjRCYmgxM1l4QU4wS2U5X0ZjeG5ER2dwZW0yZw?oc=5", "source_name": "ChartMill", "published_at": "2026-06-19T00:04:00+00:00", "published_display": "19 Jun 2026 00:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astrazeneca (AZN) Stock Drops Despite Market Gains: Important Facts to Note", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxQdFRlQ1h2eDM0VHYwa253dVlmYmdfeFBnX2s2VkVtS3RLZU5NZVBsbWs5NDVLaVRFakFhTW91QUVTTU4zM2VYSjc0Q0Exc191TGZoM0xsVnlYaGZUTzZIR0hmZmFlUU1VdFdZejR5TXdoRklwVFlLZnlSeG9Xa1ZiT1pYekZKX2pnX011MzAzS0R2ekpVaW83empGb045NUFLU0E?oc=5", "source_name": "Market source", "published_at": "2026-06-18T22:15:04+00:00", "published_display": "18 Jun 2026 22:15", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca (AZN) officer receives Ordinary Share award under incentive plan", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxOcHZERjlmdHNzTWs4azdJV2ttdkMwc240OGF1NGExRW5mUldJT3VkaFgyOFJjVmEyeTB1TjAwV0lUeHdPc045alVtSnBkbk1KcFZNTmpyMEszbnB2NFFwNnpyeGxTTnlVbkc5M21xTlZldjVLMl9lV09WbEtNYUlmR193RHpXWXNTQmpVYzV5TUp4clJEeF9RNUFFTzV0enJCLTRWbDdhYVp3WDdF?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-16T20:05:06+00:00", "published_display": "16 Jun 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FDA Accepts AstraZeneca's Filing for Expanded Use of Ultomiris", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQeHdzVmdTTU04S19jTEcycjZTaU1qN1Q4eEFlQzZ6cWVTelZpSTJQckhJOWdIaHk1TkRSdUlYZm9SZjdMVTZyM1RYS3IxVDBMbU44MUVoVWlmQ2JVcmZaYnpaZy1vdEtYU3Bickk3T2FsaGVzWUp0ekdUZjhzbzdqbWp3N3FqRmRHeXowSGJVTF9STDdaaFNTa2ZwRW9xSnpKNzk1bVNGcTB6bzNFT1RLZGNmNGpWTVRxdEE?oc=5", "source_name": "TradingView", "published_at": "2026-06-16T16:53:00+00:00", "published_display": "16 Jun 2026 16:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca Stock Down 7% in 3 Months: Should You Buy, Sell or Hold?", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxPem5qdkVUNnp0bTNzcVdSeW5IMXlkNXNzck1USGJlcmppdURocFotRHJ1aVNYS2J6VVpqeDVZS29RYWNVRXMtc1FUeDBlRTA4QThTX1U2TGMxU1NuQnptS2txaU1aUEg4VlE3amJoZ2JZUFB5Y25vU2VELTdBaWFBaV9wbDNzN25QMUhwMW4yNDEwbjA5NTZtLTg0T2J6dVN6cFFqQWh6X1AwUWdZVkpjZE90SmRtOGFwaFBNZg?oc=5", "source_name": "TradingView", "published_at": "2026-06-16T14:07:00+00:00", "published_display": "16 Jun 2026 14:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca Stock And Two Cash Flow Sleepers The Market Misprices", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-16T13:16:30+00:00", "published_display": "16 Jun 2026 13:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca PLC (AZN) Stock Analysis: Robust Revenue Growth and a 20.73% Upside Potential", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxQdlJobmhTZzJxYnJtN2NQc0dWdElmUzZyVTRSU1R2QzNsMEs0UTR0MXl3a01YZ08xZVUtU1FfNXNZRkktbGRYclhVOTdvWnZQR1J3UVhKUnhhQWw1TlMxM0JHLW9nbG9mYXozY3UtMURPdjRiWWZNNXY2ZVJBbW9tXzQzLVZyQ2FoQ2I5cUhTUjNnbVFfbnBqbk1IX2N4QXVfV09nb1FoMUlQd0s1cEpDN1JlSGhjNmRfZmdnUTYwUXBERkZScnhQMDExSWNQb2pFeEE?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-06-09T08:39:56+00:00", "published_display": "09 Jun 2026 08:39", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Too Late To Reassess AstraZeneca (LSE:AZN) After Its Strong Multi\u2011Year Run?", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxOa3VRV043YkI2dmVxQ1g2MDkyazR4b29RcmU3bHYzVDcwV2Y2SXBIVFhoZ1RERjJDUXFyQjJsTlAwemI5TFVDbHpWVXdMdGpYLWdjQndoV09aRExjang0TW9jaE53dmRCQzMwM29Ib2JGTTRhU3pjd2U2M0VsOWZZQnQwT3hNRlpVTXV0Z2pKWHBXUXhxMXNHSnRPWFBIUQ?oc=5", "source_name": "Market source", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Too Late To Consider AstraZeneca (LSE:AZN) After Its 30.8% One-Year Surge?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca chief warns group could withhold new drugs in Europe", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxOU2U1Wkd1RzVIYUFtNFRhTG5SbDNlR284cENmaWdkcVQ5TC15UmVWWkNYOWFuT1BoclBQWEowd3lONXNoRE9SOEJJTGd2alNoUUFoSElmVVo3MlhLLVFaVDBnMElfY1dDdlEyLWpsSUxuVk1lUXlKbGFWVGhieWNZV0o1dDM?oc=5", "source_name": "Financial Times", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca (LSE:AZN) Valuation Check After Recent Share Price Weakness And Pipeline Growth Expectations", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxQN1RqaFpQUXBYTjEtbkNDOVd5S1I5LTQ5ZnhlUVNya1dpbXQ3UjBjSW5iV01HYmwtSVRLSTNMR2VKa2VCM3RPVUdhZUpaQzQ1SENjUHltUk9RcDd6dUZSd1gwcHREXzhQaWk0LU5FM196VV9KR21uNXlTUmhKR3VqNzFPTXhRVjl2VnJ2aE5PbjNqYkdfY2RtLW5Ybkt1Qjc3OFVzUFJlWjgxZE9LU3N2aWU1WHVFN3V5ZkpiQXB4ekVHZFVhWEtlTlVuQnVtVF9UZ1RyRTBIMUJJWmx1bEs1eNIB5gFBVV95cUxQMjVyN3UxY2dfVFFsclR6WFNqMWxwR0o2OWZDd0NvRVlCa2J6VVlrUFQ3SFRJNmduYl9aUW90bDEzd1lxTW5mUkRGQ09CdU1QQ2lleGVLR0xWX05MSnI3b2tsWUlLMWR0U3QzZjZPeFRZODhoZWJ6aU9MLTJWT2ZVRDN2aFNSNlhGUUs5QS0weGdhLUtoNUVIMmJOUVRYT2ZUdjRRWi1lU0liVnZ6LXU4SF80UG1SXzFVUy1WWW44MXNzT0xzX3BQRmdlSnNwa1pIMUcxN3plTzZiVGVaRVVkLTNlbUxUZw?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca (AZN) admits 14,120 new employee scheme shares to LSE", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxOUlhDNWNkdzJuS3NsOWwzb2ZncDVvbk84cWEycE9TQnU2cktMVlo2bnE5UTBKTkNzSEFlTHhBaWZGMU90aFRZaW1UUVpVUnkyZ0QtaGo5YmVzalBLVzhVUk04cmR3MkxSYmlLQkptNmpXUzRZT0stSHZPSldtOWVuN2dJT2NocUNMcEZsQ2VmV1JDNS1BZUI3bF9Da0ltTDVDLTI0Y21NenFXZ2xDLTgw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca PLC Stock (AZN) Closed Down by 3.17% on Jun 1: Facts Behind the Movement", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxPVFg1VE5ObzZBRjF6RGoyVlBRTEozbE91OUI1NXlEWHg0eWR1X19rWjFqSUlnVERWTGVTOFR6YklPclJ5NEpzRVphQUZpdUpHS2libVRDYzEwN3FUZlFrd2JqeWgzMC1ac2hHNXJ5YXM2b1ZOZXJuMUhfakJGdXhYSTd2RWhTZjZjYnc?oc=5", "source_name": "TradingKey", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Fresh Look At AstraZeneca (LSE:AZN) Valuation After Recent Share Price Weakness", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNeHZ6UHg5WDVmaV9qaFNPaDNYeFlycnpOUGZwX1F3OFJtUnBGZkNfQ2RWY2Z6Ty1PeXNiUlNDSGZ3cEFwMGlKaHhySTUtdEI2cVhKVEc2YS1jV0NGMGQwZnBVLTg0cUNfa2hPS2pseDBoVERvcVQ0a1R3V2lFWjV0dU5FTFp1VzljYi11aWxYY25vNlRyb3RPbjBBQQ?oc=5", "source_name": "Market source", "published_at": "2026-05-16T07:00:00+00:00", "published_display": "16 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is AstraZeneca PLC (AZN) A Good Stock To Buy Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNX1hhOU1xaVRCYVNQNHlvd1Q1VmhpdjFybG9nUlIzai1ObmVuY3FVbmVWYUFOTkxQeW5yaTlXdkpPandQRXhHUXRNZnc0U2ZXYjN2NjFNbHA4QnhuSUZNYjJDOTFkTkp1TGs5bmNTakk5d2xWbFZWSHhuRjR5aUluTy1ST3BYNDlmeTVUd0pvRFRHSjlOUDlkRGprWQ?oc=5", "source_name": "Market source", "published_at": "2026-05-03T07:00:00+00:00", "published_display": "03 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UK's FTSE 100 Closes Lower; NatWest, AstraZeneca Shares Down", "summary": "", "url": "https://news.google.com/rss/articles/CBMifEFVX3lxTE9HVTJReEE0TnBtblpTS0xvOTRrMzB0YzZvMGRVb0NvN1dWaFhwVTB5WTlxLTFXS09lQ2hnVDZld0M4cmstRzBBdzdSME44akpxb1ZBN1d4UkJRSkk1eFNUd21GZGRwOGpZZ3prNjZOanJpTmh0QXlDXzlFMmI?oc=5", "source_name": "Market source", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UK's FTSE 100 slips as losses in energy stocks and AstraZeneca weigh", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxOU3FCZWNaMmxZQ0RzNVdQblRrMldOQkJlMEFGdVZSZVRENUEzTWdHSHJCN28xTGZFMl9tWC1NZkQtdkotbGl4Y2RQelAtekNXM2JKRzZrMklQM0hKSld3QUR5Qk51MDA5MzI4SE5JVktWM1dZRVdsTFd4dUpPTHBOcGZIeEVTdjVvbjd0ME92N2h5RlFnZGVpa3p6M09kcWlnSkxocA?oc=5", "source_name": "Reuters", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astrazeneca (AZN) Stock Falls Amid Market Uptick: What Investors Need to Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNN2Nnc0hZMHM1V0o0QlpiTUZUTElrRDMxWFZ3SUttSk41Z01OWHFRV1dyY0ZTZGVrcEplSUJaNzdsWmQ0OTliY0MwZGxSNzg0MmVOZ3k4OU1OZXJJMEdhcWhZcmhRYl9TS2wwY3hZSkpIVERJdkJEWnhYZ2NTVU56V0x0UTV1Nm95YzE5NF84UGRtek1XNHF0VjE2dUJpUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-15T07:00:00+00:00", "published_display": "15 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca admits 45,750 new shares to London Stock Exchange main market", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQaUZCRUJhTjhudnRrc3k0eG82Y1BhS3h1NjFyTGVyTzRFR0ZEWjhMT3JYRm9ka1hLYnhhT0lNemJtY3pvQVpzcFowTU51REh0MGd2TGxQSlAyQ3RSMkkwLVlDd2U2a0NrWDVlWnhxUzhPY3pmaXRHQmxyclR1LWlrUzdfSXJhZzFJdkoxWFN5ZkxKUDRRQXVuaHN4dExfZUlPNXIwejVrMnFZR3NzclNTRG5vTC1MMlpwRDBQZlA5blRxZ1dKSUFz?oc=5", "source_name": "Investing.com", "published_at": "2026-03-20T07:00:00+00:00", "published_display": "20 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca CEO hails NHS drug price deal but keeps pause on \u00a3200m UK investment", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxQU2hHTTd4c2RfUHh5MnhBSW5MZm1kaVVZRFBydTBqY0RnV1hGdGI3S1c4MDVhRDZSNmVmRXFnOTVPa3B6U2NzaEl0d1NiSGxoeEhfTEVaLVNjTjh1YnhobFlsLXdnRkFiUm5pblNaUmRhSmw3SHh6TmNNbF9ndVB1YjRPWkNGN3JCdHRMeF9Ob081Sk5zdmQzTGVYaXo5NFNURm5LamRXZWkxUmQwTW1jeHAxXzVxUFB1UGViNElhVQ?oc=5", "source_name": "The Guardian", "published_at": "2026-02-10T08:00:00+00:00", "published_display": "10 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FTSE 100 today: Index falls as BP halts buyback; AstraZeneca, Barclays in focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxNbU1zX3Nva3dsQ0k5SmNNTXQxTmc0STlHR1MzT3FZWVdpV1M0WVZIZk83LXltMWJwV09QV1BHWE13LUFWcmk5bVo1X0FVWmZQclBJM2lvTmtJOVl4N1BsdTE2Ujl6ZWFxN1dSaVplSGZMTElraW15OU1SQUQ2Ny01MDJ5eGdDNkNoWXlIQTdldjVYQ0hOZUxLUlN5TTl4NGFBMWlwU09zWWNnSk1STWFwYmREMHZVOF9oWmJFdmFNTl9rVmdYM1BqOUl3b2E?oc=5", "source_name": "Investing.com UK", "published_at": "2026-02-10T08:00:00+00:00", "published_display": "10 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca bets big on China", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxNM3lhNkJoU2tCS3U2UXRqczhIS0ZoREVidnNQR0NXUDN3bXJZeDJrM0cxRl94TE1CUy1WWXRRbEVxM3VRV1d3Q1VXNV9DS0R2OHBPdHZuOERkV3B6c2UwYWpmRGZIRkY4c0dyR3Jjc3lkUTNUYVZEamxQUVp6THo5cDFB?oc=5", "source_name": "fDi Intelligence", "published_at": "2026-02-09T08:00:00+00:00", "published_display": "09 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca begins trading on the New York Stock Exchange", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPMWtuQzczY3ltajY4cUdBOVJGcEdDcXN1Nk12RVhwWU9MYXFvYzc1ckpZeHB3bnFlQ1A2OG01S3lTUDJqQUdEYUVXS2FpTXBudVdYTC1aX2I0MGRUdVNSMzBJRGZtTnM3YTNXcXp0eEVWaEpJb1E0TTlWY2J5VjNSdWtjQTFIMV8ySENONTJ5MzI2ZHVvLWFjaUtpejRacWxELXc?oc=5", "source_name": "AstraZeneca", "published_at": "2026-02-02T08:00:00+00:00", "published_display": "02 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca begins trading on New York Stock Exchange", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxPYlI0TUlrcEVEMXBEcjlKT2tWNi10X1IxUFctMmxGY0JibnFQZG5vM2tya2lEY0Q1YVQ2bHdqT0tzckpmNnlIRzUzd3hpUzBKenBUX2ZRckRia1NOTk13amx1Q25ZeGsxS3VjVk1wT0Z0NXVJVW91ejUxYXZvWmFPYkFCWk4wc1BRMXdmeVBRRVVPRTdB0gGaAUFVX3lxTE1qdEhsdGFONWxpZ2k4NlJNcEhWUU04UmtmVUVvNmtybk12UHkwMnR5eHNtcmdlYkM4a21tVFk2MjUwWU9aakNnTXlWMzFnUGVYdEw0Q0dNZkdHamx2ZzA1NzVwSEQxNTFUcTdsSU9jc2NTckkxMlJnSHRZYjY3VVItX0ZHaF83WmJyM2t5OTZMNURyYnFydWlFbmc?oc=5", "source_name": "Business Live", "published_at": "2026-02-02T08:00:00+00:00", "published_display": "02 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca to complete direct listing of ordinary shares and all US debt securities on the New York Stock Exchange", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQY3QzY1NFN2NGUEJWNkdXcDlObHh4azVkY0YzRzBtZzItYWpiSmxqc1Y5RmxLYkVzbi1oWVhubHY5azRzYkpTVFRWY2I5SzluelBCMUtXdkJQVURUWDU0bFBTLWxwUkVlWG1obk5YSFBXTlF6YkNiRFhCRkNhcHhBeE55N1R0TWxhNUVmdkZ5WXR5dWU3YmpTUE93SFQ4RDV3TjQ3OGxfdDNHNXNrVWlCOWxn?oc=5", "source_name": "AstraZeneca", "published_at": "2026-01-20T08:00:00+00:00", "published_display": "20 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca Stock Becomes UK\u2019s Biggest Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMifkFVX3lxTE5nYVRlM2RkSVpIYklFdE1CcGZQbXRES3djZVA5NTFHZUpBVVRDSWoxaUF2X1VZZkpSRmtiUlhOQnY1UDl2UlN0WUxGY3hFbTU2VF83b2xEUklVYU1GS29iRDRDWFRPMjMtMXoxMnlENUFyOTFEV1ZOUzBIcmN0QQ?oc=5", "source_name": "Pharmaceutical Executive", "published_at": "2025-11-11T08:00:00+00:00", "published_display": "11 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FTSE 100 closes at record high on rate cut bets; AstraZeneca shines", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxOQkpMUVhlQ2d3QzZ3THRrdEhRWG0wSFR4Z094NDlqN1JJdmNVV0xBYzZtSUlZM3c2bExMVXVoOE1rSUl0SzczS1RXaVlIOXRoSDJSSVpYWjFTb2hvbzMxaWZkTTZid2t4eVNZcFh3SUJRb1JaYnk3VWRUaC1vNEx4MVR4aTR6ei00eTNrOWxJMEF0Nmo0N1B4d29mQUVHaGlVUmt4RmExLUFKZ1BpRFRYQnJhbUZUMlQ2aUR2S01jODNqc1F5WTJpOU1QYURYUQ?oc=5", "source_name": "Reuters", "published_at": "2025-11-11T08:00:00+00:00", "published_display": "11 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca to upgrade US listing in \u2018knock-back for London\u2019", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPdnlmNE5tNzNsZGU3NmdaU0dNSDZkZTlDdmp3WkRmWHA3cXZkQ28xMWl2Q0RmZkliN0pDOWNDbDhfZ3g0VElVRVJrc0hBVEFwZ2d5YzlGMUFnN1hSRURiTmVVdXhxRXNSTmljbDdyZEVDNXFXeVFfZUdPQlEyb0RfcjVLb3VURWdfRDEzeXdIWjIxTno5Qkc5cVZ2cTRxQmVlNkUyVEpYaTNTX3ltM3BUZHQwQmVNckNUcG5QUS1Ic2E?oc=5", "source_name": "The Guardian", "published_at": "2025-09-29T07:00:00+00:00", "published_display": "29 Sep 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "'Knock-back for London' as AstraZeneca sells shares directly on rival New York Stock Exchange", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQSzh0UHpoVjlBcUJNMVNPVjBRUEFSLXpfemZIM3VKc212QzFweTJxVkt0V0VPbldnaklzRUdEdzRmX3Q2Q29FRlgwUERqNGZ5bFIwZzlwOERFNUg4bXFIMVg3VEdpZFZHR0F6MVlnTlV0SnlhYVNxVm5GUmhaLXpsbnFuR0tyZ3BVekNULVV4ZXktczVGb254RDBZazRlM0RrZ2RNeGt1QnRVR0prNnNEUXdOVVVSME9ZOWJaQ2RYS2dPbTBSeGc?oc=5", "source_name": "Sky News", "published_at": "2025-09-29T07:00:00+00:00", "published_display": "29 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca to harmonise its listing structure across the London Stock Exchange, Nasdaq Stockholm and New York Stock Exchange", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgJBVV95cUxOUm01dC1PRGdrMVR1YlhsX2ZHa0FNUTdRU2QzenJuOVdJVlBadHJCVmRfTEJEZFNuNWlSZFZrYzNFSVlCU2I4MkxHUWZ0bU5TS1BXNFhKbE1OUl9STllKTGRjd2VzZ2RUdjNxS3RtUmlZR3dsV3FEVEJqSU92RGQzMVJJSlZXckxoNzNMLWxwNWRxUVRTaE5wTTBrWHJPTDc0SWNQNjhaeGplelZGc3dudkY5WVJjejE3aUV2MnExZHBSQnBGXzZKWTVrSU5DYlByanUxVm1BVXl5VHZDa3dCVlYyUUVKQWdQNHVMd3JmWGh3X05Nc041aDFXU2pEVXBRNndOZ29IR29hX18yZ0xpUGdiWl9CNHJxWmc?oc=5", "source_name": "AstraZeneca", "published_at": "2025-09-29T07:00:00+00:00", "published_display": "29 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca to overhaul US listing but remain on London market and keep UK HQ", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxObGlaNVhDd1VTbnRXdnE0OEpVTjR2dlZIX0RZOUpjaV9FOWZIZ3Vic1IwRGVNT1puSmVtSUxMOVp3a2tBdFBiTzBuSlNiRGdqak8xTmRLMGVUalFwU2ktWVR2VHhHMXk0VzFuYzBYUG1BdW1GSm4zdnRDS2VEOTRaZU0zLXNjMmVZTHlTZ3VDVlo?oc=5", "source_name": "Market source", "published_at": "2025-09-29T07:00:00+00:00", "published_display": "29 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 78, "total_relevant": 36, "sentiment_summary": {"positive": 7, "negative": 5, "neutral": 24, "score": 51, "total": 36, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 89, "events": [{"event": "general", "label": "Market update", "weight": 17.55, "count": 30}, {"event": "liquidity", "label": "Balance sheet", "weight": 1.1, "count": 2}, {"event": "deals", "label": "Deals and strategy", "weight": 0.9, "count": 1}, {"event": "analyst", "label": "Analyst action", "weight": 0.9, "count": 1}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}, {"event": "capital_return", "label": "Capital return", "weight": 0.55, "count": 1}], "positive_events": 7, "negative_events": 5}, "market_context": {"has_market_context": true, "latest_close": 13234.0, "latest_week": "2026-06-19", "one_week_move": -1.7, "four_week_move": -4.9, "twelve_week_move": -7.5, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.163622, "market_dynamics_buy_signal": false, "relative_strength": -3.987556, "fair_value_gap": 12.5, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "positive", "expectation_probability": 62.9693, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-1.7% over one week, -4.9% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 62, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 9}, {"label": "simplywall.st", "count": 4}, {"label": "AstraZeneca", "count": 3}, {"label": "Kalkine Media", "count": 2}, {"label": "Stock Titan", "count": 2}, {"label": "TradingView", "count": 2}, {"label": "Reuters", "count": 2}, {"label": "The Guardian", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 36}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 30}, {"label": "Balance sheet", "count": 2}, {"label": "Earnings", "count": 1}, {"label": "Deals and strategy", "count": 1}, {"label": "Capital return", "count": 1}, {"label": "Analyst action", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "51/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "89/100 classification confidence."}, {"label": "Company focus", "value": "36", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "5", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-1.7% over one week, -4.9% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Why AstraZeneca (LSE:AZN) Is Reframing Blue-Chip Stocks"}], "updated_at": "2026-06-22T20:02:07.305664+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}